 A series of cycloalkanecarboxamide containing sulfonate and sulfamate derivatives were prepared and their antiproliferative activity was tested against NCI 60 cancer cell lines panel . Compound

@highlight Antiproliferative activity of a series of cycloalkanecarboxamides is reported.
@highlight Compound
@highlight is the most active with broad spectrum antiproliferative activity.
@highlight Compound
@highlight is the most potent against HT29 colon cancer cell line IC
@highlight  4.73M .
@highlight Compound
@highlight is 4.23 times more selective toward HT29 than normal fibroblasts.
@highlight Compound
@highlight induces apoptosis in HT29 colon cancer cell line.
